Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Fader, Amanda N
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 07 2018 - 2044-2051 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
1527-7755
10.1200/JCO.2017.76.5966 doi
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carboplatin--administration & dosage
Cystadenocarcinoma, Serous--drug therapy
Female
Humans
Middle Aged
Neoplasm Staging
Paclitaxel--administration & dosage
Progression-Free Survival
Receptor, ErbB-2--biosynthesis
Trastuzumab--administration & dosage
Uterine Neoplasms--drug therapy
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 07 2018 - 2044-2051 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
1527-7755
10.1200/JCO.2017.76.5966 doi
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carboplatin--administration & dosage
Cystadenocarcinoma, Serous--drug therapy
Female
Humans
Middle Aged
Neoplasm Staging
Paclitaxel--administration & dosage
Progression-Free Survival
Receptor, ErbB-2--biosynthesis
Trastuzumab--administration & dosage
Uterine Neoplasms--drug therapy